Attached files
| file | filename |
|---|---|
| 10-Q - INNOVUS PHARMACEUTICALS, INC. | form10q11930v2.htm |
| EX-31 - INNOVUS PHARMACEUTICALS, INC. | exhibit311.htm |
| EX-31 - INNOVUS PHARMACEUTICALS, INC. | exhibit312.htm |
| EXCEL - IDEA: XBRL DOCUMENT - INNOVUS PHARMACEUTICALS, INC. | Financial_Report.xls |
EXHIBIT 32.1
Section 1350 Certification
In connection with the Quarterly Report of North Horizon, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2011, as filed with the Securities and Exchange Commission (the “Report”), I, Wallace Boyack, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. SS. 1350, as adopted pursuant to SS. 906 of the Sarbanes-Oxley Act of 2002, that:
1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and |
2. | The information contained in the Report fairly presents, in all material respects, the financial conditions and results of operations of the Company. | ||
|
| ||
October 19, 2011 |
| /s/Wallace Boyack, Wallace Boyack, Chief Executive Officer, Chief Financial Officer, principal executive officer, principal financial and accounting officer | |